相关实验视频

Updated: Sep 10, 2025

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium

Published on: May 6, 2018

VEGFR1作为心血管基因治疗的目标

Yosef Eshetie Amare^1,2, Roman Vuerich¹, Serena Zacchigna^3,4

¹Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

Journal of cardiovascular translational research

|August 21, 2025

概括

血管内皮生长因子受体1 (VEGFR1) 在心血管疾病中起着双重作用. 本综述探讨了VEGFR1的功能和治疗这些疾病的基因治疗策略.

科学领域:

心血管生物学
分子医学
基因治疗

背景情况:

血管内皮生长因子受体1 (VEGFR1) 对内皮功能,血管生成,炎症和心肌细胞存活至关重要.
在心血管疾病 (CVD) 的背景下,VEGFR1具有有益和有害的作用.
心血管疾病对全球健康构成重大负担,需要新的治疗方法.

研究的目的:

审查控制VEGFR1功能的分子生物学.
阐明VEGFR1在常见心血管疾病的发展和进展中的特定作用.
讨论针对VEGFR1异型 (膜结合和可溶性sFLT1) 的基因治疗策略.

主要方法:

文献审查侧重于VEGFR1的分子机制及其在心血管病理中的参与.
在与心血管疾病相关的不同细胞类型中分析VEGFR1介导的信号通路.
对针对VEGFR1及其异型的现有和潜在基因治疗方法的研究.

主要成果:

VEGFR1信号与心血管疾病的关键病理过程有关,包括异常血管生成和炎症.
膜结合的VEGFR1及其溶解形式sFLT1在心血管健康和疾病中发挥着独特而重要的作用.
基因疗法为调节VEGFR1活性以对抗心血管疾病提供了一个有希望的途径.

结论:

VEGFR1是心血管疾病发病的一个关键媒介,具有潜在的治疗点.
了解不同细胞类型的VEGFR1信号复杂性对于有效的治疗开发至关重要.
通过基因疗法向VEGFR1或其异型,为新型心血管疾病治疗提供了显著的潜力.

关键词:

血管新生心血管疾病基因治疗

更多相关视频

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...